You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 125 No. 4, April 1989 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Observations and Proposed Mechanism of N,N',N''-Triethylenethiophosphoramide (Thiotepa)-Induced Hyperpigmentation

Thomas D. Horn, MD; Roy A. Beveridge, MD; Merrill J. Egorin, MD; Martin D. Abeloff, MD; Antoinette F. Hood, MD

Arch Dermatol. 1989;125(4):524-527.


Abstract



• After receiving N,N',N''-triethylenethiophosphoramide (thiotepa) and cyclophosphamide intravenously, five women with metastatic adenocarcinoma of the breast developed a patterned hyperpigmentation confined to skin occluded by adhesive-containing materials. Determinations of thiotepa concentrations in occluded and nonoccluded skin, plasma, bandage with adhesive, and gauze containing sweat were performed. The results suggest that this alkylating agent is excreted onto the skin surface in sweat, accumulates beneath adhesivecontaining bandages and electrocardiogram pads, and exerts a local toxic effect resulting in hyperpigmentation.

(Arch Dermatol 1989;125:524-527)



Author Affiliations



From the Departments of Dermatology (Drs Horn and Hood) and Oncology (Drs Beveridge and Abeloff), Johns Hopkins Hospital; and the University of Maryland School of Medicine and Division of Developmental Therapeutics, University of Maryland Cancer Center (Dr Egorin), Baltimore.


Footnotes



Accepted for publication Oct 19, 1988.

Reprint requests to Department of Dermatology, Johns Hopkins Hospital, Blalock 913F, 600 N Wolfe St, Baltimore, MD 21205 (Dr Horn).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intertriginous Eruption Associated With Chemotherapy in Pediatric Patients
Webber et al.
Arch Dermatol 2007;143:67-71.
ABSTRACT | FULL TEXT  

Chemotherapy-Induced Eccrine Squamous Syringometaplasia: A Distinctive Eruption in Patients Receiving Hematopoietic Progenitor Cells
Valks et al.
Arch Dermatol 1997;133:873-878.
ABSTRACT  

Antineoplastic Chemotherapy, Sweat, and the Skin
Horn
Arch Dermatol 1997;133:905-906.
ABSTRACT  

Eccrine Squamous Syringometaplasia: A Cutaneous Sweat Gland Reaction in the Histologic Spectrum of `Chemotherapy-Associated Eccrine Hidradenitis' and `Neutrophilic Eccrine Hidradenitis'
Hurt et al.
Arch Dermatol 1990;126:73-77.
ABSTRACT  

Cutaneous Eruptions of Lymphocyte Recovery
Horn et al.
Arch Dermatol 1989;125:1512-1517.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.